Join to view full profile
1100 Fairview Avenue N.Seattle, WA 98109
Phone+1 206-667-1912
Dr. Paulovich is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2000 - 2004
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1998 - 2000
University of Washington School of MedicineClass of 1998
Certifications & Licensure
WA State Medical License 2004 - 2027
MA State Medical License 2002 - 2005
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2012
Publications & Presentations
PubMed
- Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer.Scott Best, Daniel S Hippe, Eli Grunblatt, Jackson Fatherree, Pritha Chanana
Nature Communications. 2026-07-08 - 1 citationsLongitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance.Kelsi M Chesney, Jeffrey R Whiteaker, Brian Hood, Ming Zhou, Huizen Zhang
Cells. 2026-03-05 - 7 citationsThe DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study.Timothy A Yap, Patricia LoRusso, Rowan E Miller, Rebecca Kristeleit, Amanda G Paulovich
British Journal of Cancer. 2025-08-01
Press Mentions
Combination Therapy Shows Promising Results in Treating Stage 3 MelanomaOctober 31st, 2024- First Large-Scale Proteogenomic Analysis of Pediatric Brain Tumors CompletedNovember 25th, 2020
- First Large-Scale Proteogenomic Analysis Offers Insights into Pediatric Brain TumorsNovember 25th, 2020
Grant Support
- Optimizing pre-analytical variables for reliable mass spectrometry-based quantification of immunomodulatory proteins in cerebrospinal fluid in pediatric neuro-oncology trialsFRED HUTCHINSON CANCER CENTER2025–2030
- Clinical translation of a NexGen platform for quantifying protein networks in human biospecimensFRED HUTCHINSON CANCER CENTER2019–2029
- Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environmentFRED HUTCHINSON CANCER CENTER2023–2028
- Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapiesFRED HUTCHINSON CANCER CENTER2022–2027
- Proteo-Genomic Discovery, Prioritization And Verification Of Cancer BiomarkersNational Cancer Institute2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
